Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-02-05
1981-02-03
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
26032614T, 26032647, 260404, 260413, 424274, 564188, 564190, A61K 31165, A61K 3140, C07C10320, C07C10337
Patent
active
042488931
ABSTRACT:
Cyclopropanyl-group-bearing-amides, eg N-[1-(benzyl)-2-(phenyl)ethyl]-cis-2-octyl-cyclopropanoctanamide and N-(.alpha.-methyl-benzyl)-(cis)-2-octyl-cyclopropanoctanamide, are useful as pharmaceutical agents and are obtainable, eg by reacting a mixed anhydride of a cyclopropanyl-group bearing-long chain carboxylic acid with an appropriate amino compound.
REFERENCES:
patent: 2811532 (1957-10-01), Riedman
patent: 3621043 (1971-11-01), Seki
patent: 3741999 (1973-07-01), Seki
patent: 3995059 (1976-11-01), Fukumaru
Fieser & Fieser, Advanced Organic Chem. (1961) p. 549.
Heider John G.
Kathawala Faizulla G.
Fagelson Anna P.
Sandoz Inc.
Sharkin Gerald D.
Vila Richard E.
Weinfeldt Frederick H.
LandOfFree
Arterial wall cholesterol ester reducing cyclopropanyl-bearing a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arterial wall cholesterol ester reducing cyclopropanyl-bearing a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arterial wall cholesterol ester reducing cyclopropanyl-bearing a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-551115